Home / Companies / News / GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr

GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr

The company had posted a net profit of Rs 146.81 crore for the same period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

Premium

Consolidated revenue from operations stood at Rs 775.80 crore for the quarter under consideration. It was Rs 750.81 crore in the same period a year ago.

Agencies

1 min read Last Updated : May 19 2020 | 12:22 AM IST

Drug firm GlaxoSmithKline Pharmaceuticals on Monday reported a 5.95 per cent decline in its consolidated net profit to Rs 138.07 crore for the fourth quarter ended March 31, 2020.

The company had posted a net profit of Rs 146.81 crore for the same period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

ALSO READ: Bharti Airtel slips into red; posts Rs 5,237 cr loss for Jan-Mar quarter

Consolidated revenue from operations stood at Rs 775.80 crore for the quarter under consideration. It was Rs 750.81 crore in the same period a year ago.

Topics : GlaxoSmithKline GlaxoSmithKline Pharmaceuticals Q4 earnings Q4 Results Pharma Companies BSE

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in